Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 104 sells.

Estimated insider holdings value: $175.6M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$175.41M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$184.4K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 9 filings (page 10)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 8, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	19,442	$235.51	$4,578,763.75	-22.7%	+33.7%	+18.0%
Apr 4, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$231.92	$6,957,709.48	-31.1%	+33.0%	+25.0%
Apr 2, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$228.69	$6,860,825.07	-23.4%	+39.6%	+36.6%
Mar 28, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	29,125	$239.05	$6,962,298.44	-17.3%	+38.8%	+33.6%
Mar 26, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$245.84	$7,375,339.23	-24.4%	+28.7%	+25.4%
Mar 22, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$236.70	$7,100,981.03	-31.0%	+29.9%	+31.6%
Mar 20, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$236.27	$7,088,195.57	-28.0%	+29.3%	+32.5%
Mar 18, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	30,000	$235.54	$7,066,147.21	-31.3%	+27.0%	+34.3%
Mar 14, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	1,425	$240.58	$342,821.71	-77.3%	+18.4%	+29.0%

← PrevPage 10

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC